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osting by EAbstract Cutaneous involvement is a well-recognized manifestation of Crohn’s disease. The inci-
dence of these manifestations varies widely and occur in 14–40% of patients with Crohn’s disease.
These can be either metastatic, contiguous or reactive. Cutaneous Crohn’s disease, also known as
metastatic Crohn’s disease, refers to noncaseating cutaneous granulomatous lesions that are not
contiguous with intestinal Crohn’s disease. This clinical presentation is rare, especially in children.
We report a case of metastatic Crohn’s disease manifesting as scrotal swelling and eczematous
eruption over genitalia and around anus in a 6 years old boy which dramatically responded to
Metronidazole.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Case report
A 6 year-old boy presented with 6 months history of a progres-
sive, asymptomatic scrotal swelling and eczematous eruption
over perianal region. No other symptoms were present at the
time of presentation. No history of abdominal pain, nausea,
vomiting, diarrhea or bloody stool. No history of inﬂammatory
bowel disease. General examination conﬁrmed that the patient1426; mobile: 0555445518.
m (F. Al-Saif).
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lsevierwas in good health. Height and weight percentiles were normal
for age. Skin examination revealed dramatic edema of the scro-
tum and well-deﬁned, indurated, erythematous, ﬁssured eczem-
atous lesions over perianal and anal areas (Figs. 1–3). Skin
biopsy showed: parakeratosis and spongiosis of the epidermis,
along with marked chronic inﬂammatory cell inﬁltration, gran-
uloma formation, and foreign body giant cell reaction in the der-
mis. PASD, AFB, and GMS stains were negative. Blood tests
including: CBC, ESR, LFT, U/E, C-reactive protein, were all
normal. Patient was then evaluated by a pediatric gastroenterol-
ogist who conﬁrmed that patient has GI involvement consistent
with Crohn’s disease. The patient was treated with Metronida-
zole 125 mg/ml twice daily for one month which resulted in al-
most complete clearance of the skin lesions (Figs. 4–6).
2. Discussion
Crohn’s disease, a chronic granulomatous inﬂammatory disor-
der of the intestine, was ﬁrst described by Crohn, Ginzburg,
and Oppenheimer (Crohn et al., 1932) in 1932. It often begins
Figure 5 Anogenital area lesions almost resolving.
Figure 6 Dramatic improvement over anal and perianal regions.
Much less erythema with no ﬁssuring.
Figure 1 Marked bilateral scrotal erythema and swelling.
Figure 2 Erethamatous – edematous lesion extend to the anal
cleft.
Figure 3 Erythematous, ﬁssured plaques over the anus and the
perianal region.
Figure 4 Scrotal swelling almost resolves after one month of
treatment with metronidazole.
68 A.A. Summaree et al.between the second and fourth decades of life (Greenstein
et al., 1976; Shum and Guenther, 1990), but one third of cases
of intestinal Crohn’s disease developed before age 20 years
(Booth and Harries, 1984; Mekhjian et al., 1979). Cutaneous
Crohn’s disease (C-CD) refers to granulomatous noncaseating
cutaneous lesions, separated from primary gastrointestinal af-
fected areas by absolutely normal skin (Shum and Guenther,
1990; Parks et al., 1965; Gregory and Ho, 1992; Burgdorf,
1981; McCallum and Kinmont, 1968).
These lesions are rare and are easily misdiagnosed, espe-
cially when the characteristic gastrointestinal symptoms are
absent (Shum and Guenther, 1990). They are to be distin-
guished from contiguous lesions, which are complications
due to direct skin involvement from the gastrointestinal dis-
ease, e.g., perianal, peristomal, and periﬁstular inﬂammations
(Gregory and Ho, 1992; Burgdorf, 1981; McCallum and Kin-
mont, 1968). The pathogenetic mechanism by which these skin
lesions develop is enigmatic (Crowson et al., 2003). Skin le-
sions occur in 14–44% of patients with Crohn’s disease (CD)
Greenstein et al., 1976; Magro et al., 1997; Buckley et al.,
1990, and are seen most commonly in patients with colonic
involvement and generally unrelated to the activity of bowel
disease (Veloso, 2004). The most common cutaneous reaction
pattern is associated with dermal tissue neutrophilia, encom-
passing Sweet’s syndrome (SS), PG Buckley et al., 1990;
Tiveljung et al., 1999; Petermann et al., 1999, bowel dermato-
sis-arthritis syndrome (Delaney et al., 1989), perioriﬁcial pyo-
derma (Smoller et al., 1990), pyoderma faciale (McHenry
et al., 1992), and a sterile neutrophilic folliculitis with perifol-
licular vasculitis (Magro and Crowson, 1998). Cutaneous
Crohn’s disease can be divided into two forms: genital (56%)
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children with cutaneous Crohn’s disease had genital involve-
ment compared with approximately 50% of adults with cuta-
neous Crohn’s disease (Ploysangam et al., 1997).
Examination of a child with genital or anal disease may give
rise to suspicion of sexual abuse and genital Crohn disease
has often been mistaken as such (Stratakis et al., 1994; Sellman
et al., 1996). Clinically, the lesions may manifest as subcutane-
ous nodules or erythematous plaques and secondary ulcers
(Veloso, 2004).
Our patient presented with eczematous lesions which is
unusual for cutaneous Crohn’s disease. Treatment is often
unsatisfactory: randomized controlled trials are lacking; met-
ronidazole, steroids, and sulfasalazine are helpful (Ploysangam
et al., 1997), but complete resolution is uncommon and unpre-
dictable (Pinna et al., 2006). Surgical removal of the diseased
bowel does not necessarily improve cutaneous Crohn’s disease
(Cockbum et al., 1980).
The value of metronidazole in treating perineal Crohn’s dis-
ease is convincingly demonstrated in the literature, which
prompted us to use it for our patient with a dramatic response.
The exact mechanism of action of metronidazole in Crohn’s
disease remains to be elucidated, but its antimicrobial, anti-
inﬂammatory and immunosuppressive properties may be of
signiﬁcance (Ursing et al., 1982). Prolonged administration
of metronidazole is associated with a number of adverse ef-
fects. The most important symptom is bilateral pedal paresthe-
sia (Brandt et al., 1982), other side-effects include a metallic
taste, darkening of urine, nausea, anorexia, fatigue, headache,
glossitis, urticaria and reversible Neutropenia (Bernstein et al.,
1980).
3. Conclusion
We here describe a case of cutaneous Crohn’s disease, present-
ing as eczematous plaques over scrotum, and perianally in a
6 years old child, which improved dramatically on oral metro-
nidazole for one month.
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